Efficacy, safety of hydroxychloroquine vs placebo to prevent SARS-CoV-2 infection among health care
(JAMA Network) In this randomized clinical trial, daily hydroxychloroquine didn't prevent SARS-CoV-2 infection among hospital-based health care workers, although the trial was terminated early.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news
More News: Clinical Trials | Health Management | Hospitals | Hydroxychloroquine | Infectious Diseases | SARS